Skip to content

PTC Therapeutics PTCT Change in Other Assets

Change in Other Assets at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
-$1.48M-191%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$18.85M+3,770%
Arrowhead Research logo
Arrowhead ResearchARWR
$13.18M+2,127%
ALN
Alnylam PharmaceuticalsALNY
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$6.55B+40.3%
Enterprise value$6.11B+77.3%
P/E
P/S7.9×+5.3×

Profitability

See full
Gross margin96%
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%
Debt / equity372.3×
Current ratio2.4×-1.5×

Where this comes from

Reported directly by PTC Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTC Therapeutics's change in other assets?
PTC Therapeutics (PTCT) reported change in other assets of -$1.18M in Q1 2026.
How has PTC Therapeutics's change in other assets changed year-over-year?
PTC Therapeutics's change in other assets decreased by 107.2% year-over-year, from $16.43M to -$1.18M.
What is the long-term trend for PTC Therapeutics's change in other assets?
Over 3 years (2021 to 2024), PTC Therapeutics's change in other assets has grown at a 91.8% compound annual growth rate (CAGR), from $15.31M to -$107.96M.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.